AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI EP News Bureau Dec 22, 2020 Benralizumab is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
AstraZeneca India receives marketing permission for QTERN EP News Bureau Sep 26, 2019 Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…
